Skip to main content

Veterinary Medicine

Volume 458: debated on Monday 19 March 2007

To ask the Secretary of State for Environment, Food and Rural Affairs what veterinary uses are permitted for (a) kanamycin and (b) neomycin; and how much of each medicine was used in the UK in each of the last five years. (128107)

There have been no veterinary pharmaceutical products authorised for sale on the UK market in the last five years that include kanamycin.

Neomycin is present as an active substance with antimicrobial activity in a number of veterinary medicinal products with several routes of administration including topical, oral and injectable. It is a broad spectrum antibiotic active against a number of gram-positive and gram-negative bacteria.

The following table details how much neomycin was sold for veterinary use on an annual basis in the UK, for the last five years for which data are available.

Tonnes of Neomycin active ingredient sold

Number of products included

2001

5.18

17

2002

5.22

20

2003

3.45

18

2004

4.51

15

2005

4.92

9